US 12239715
Peptide oligonucleotide conjugates
granted A61KA61K38/00A61K47/18
Quick answer
US patent 12239715 (Peptide oligonucleotide conjugates) held by Sarepta Therapeutics, Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/00, A61K47/18, A61K47/645, A61P